Impaired Endothelial Release of Tissue-Type Plasminogen Activator in Patients With Chronic Kidney Disease and Hypertension-Reference-Cited by-同舟云学术

Impaired Endothelial Release of Tissue-Type Plasminogen Activator in Patients With Chronic Kidney Disease and Hypertension

Published:2004-09 Issue:3 Volume:44 Page:300-304
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Hrafnkelsdóttir Thórdís¹,Ottosson Pia¹,Gudnason Thorarinn¹,Samuelsson Ola¹,Jern Sverker¹

Affiliation:

1. From the Clinical Experimental Research Laboratory (T.H., T.G., S.J.), Sahlgrenska University Hospital/Östra, and the Department of Nephrology (P.O., O.S.), Sahlgrenska University Hospital/Sahlgrenska, Göteborg University, Sweden.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference32 articles.

1. Regulation of the Acute Release of Tissue-type Plasminogen Activator from the Endothelium by Coagulation Activation Products

2. The Fibrinolytic Potential of the Normal Primate following the Generation of Thrombin In Vivo

3. Impaired capacity for endogenous fibrinolysis in essential hypertension

4. Cardiovascular risk in end-stage renal disease: vascular aspects

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Management of Emerging or Unconventional Risk Factors-2”;Ischemic Stroke Therapeutics;2024

2. Challenges in the evaluation of endothelial cell dysfunction: a statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors;Journal of Hypertension;2022-12-22

3. Fibrinolysis Shutdown and Hypofibrinolysis Are Not Synonymous Terms: The Clinical Significance of Differentiating Low Fibrinolytic States;Seminars in Thrombosis and Hemostasis;2022-11-01

4. Alteplase for Stroke With Unknown Onset Time in Chronic Kidney Disease: A Pooled Analysis of Individual Participant Data;Stroke;2022-11

5. SARS-CoV-2 Infection, Sex-Related Differences, and a Possible Personalized Treatment Approach with Valproic Acid: A Review;Biomedicines;2022-04-21